首页 | 本学科首页   官方微博 | 高级检索  
检索        

同步放化疗治疗局部晚期食管癌临床观察
引用本文:熊琦,方福平,徐元亮.同步放化疗治疗局部晚期食管癌临床观察[J].肿瘤基础与临床,2011,24(2):119-121.
作者姓名:熊琦  方福平  徐元亮
作者单位:罗山县人民医院放疗科,河南,罗山,464200
摘    要:目的 探讨同步放化疗治疗局部晚期食管癌的疗效及毒副反应.方法 80例经组织学或细胞学证实的局部晚期食管癌随机分为两组,同步放化疗组40例接受同步放化疗,单纯放疗组40例仅接受放疗,化疗采用DF方案,放疗剂量为60-64 Gy,治疗结束后分别观察疗效及毒副反应.结果 同步放化疗组和单纯放疗组有效率分别为95.0%、82....

关 键 词:食管癌  放疗  化疗  同步放化疗

Clinical Observation of Concurrent Radiotherapy and Chemotherapy in the Treatment of Locally Advanced Esophageal Cancer
Xiong Qi,Fang Fuping,Xu Yuanliang.Clinical Observation of Concurrent Radiotherapy and Chemotherapy in the Treatment of Locally Advanced Esophageal Cancer[J].journal of basic and clinical oncology,2011,24(2):119-121.
Authors:Xiong Qi  Fang Fuping  Xu Yuanliang
Institution:(Department of Radiotherapy,Luoshan People′s Hospital,Luoshan 464200,China)
Abstract:Objective To evaluate the efficacy and toxicities of concurrent radiotherapy and chemotherapy in the treatment of locally advanced esophageal cancer.Methods Eighty patients with locally advanced esophageal cancer were divided into two groups.The 40 patients in the concurrent radiotherapy and chemotherapy group were treated with concurrent radiotherapy and chemotherapy;the other 40 patients in the radiotherapy group were treated with radiotherapy alone.The chemotherapy regimen was DF regimen,the radiotherapy dosage was 60-64 Gy.The efficacy and toxicities were respectively observed after treatment.Results The response rate was 95.0% in the concurrent radiotherapy and chemotherapy group,and was 82.5% in the radiotherapy group(P>0.05).The 1-,2-and 3-year survival rates were 47.5%,35.0%,25.0% in the concurrent radiotherapy and chemotherapy group,and were 32.5%,25.0%,12.5% in the radiotherapy group(P>0.05).There were no serious toxicities in the two groups;there was no significant difference in the incidence rates of the two groups(P>0.05).Conclusion The efficacy of concurrent radiotherapy and chemotherapy seems to be better than that of the radiotherapy alone in the treatment of locally advanced esophageal cancer,and does not increase the serious toxicities.
Keywords:esophageal cancer  radiotherapy  chemotherapy  concurrent radiotherapy and chemotherapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号